Essais liés3clinical trials
VilleSan Sebastiánlocalisation
PaysSpainlocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT06486441

Ouvrir le site du centre

Essais cliniques associés

3
MoléculeIndication / populationPhaseNCTTitreStatut
Del-desiran (AOC 1001) Myopathies Phase 3 NCT07008469 HARBOR-OLE — Global Open-Label Extension Study of Del-desiran for the Treatment of DM1 ENROLLING_BY_INVITATION
AOC-1020 Myopathies Phase 3 NCT07038200 FORTITUDE-3 — A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD RECRUITING
Sacituzumab govitecan-hziy Cancer Phase 3 NCT06486441 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26) ACTIVE_NOT_RECRUITING